In another study, the same group silenced the expression of PD-L1 in DCs and PD-1 in T lymphocytes, once again using the siRNA-loaded NPs platform and evaluated the DC phenotypic and functional characteristics and T-c lymphocyte functions following tumor antigen recognition on DCs, ex vivo. This evidence concerns the gene PDCD1 and neoplasm.